Literature DB >> 7381205

The first component of complement. I. Purification and properties of native C1.

R G Medicus, R M Chapuis.   

Abstract

The first component of complement has been purified by using affinity chromatography on Sepharose-bound IgG. Unlike earlier procedures that yield the activated form of C1, in this method C1 is maintained in the native form by the protease inhibitor p-nitrophenyl, p'-guanidinobenzoate (NPGB). The procedure requires only two steps and yields pure C1 as judged both by SDS-PAGE analysis and by effective molecule calculations. The yields have varied from 30 to 50% in over 50 preparations. The functional properties of the purified native C1 correspond to those of C1 in serum. The dose-response activity profile is nonlinear, but becomes linear when C1 IS ALLOWED TO SELF-ACTIVATE. From SDS-PAGE analysis of the self-activated C1, all the C1r and C1s subcomponents are converted to the activated split products, indicating that all C1 molecules are biologically active. The recovery of C1 activity is dependent on the use of a heterologous source for the IgG on the affinity absorbant. The conditions of binding and elution from the Sepharose-IgG column are critical, indicating that immunoglobulin-bound C1 is rapidly inactivated under physiologic conditions by serum inactivators. The activation of the purified C1 in fluid phase has been explored both in the presence and absence of C1-inhibitor.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7381205

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Ultrastructure of the first component of human complement: electron microscopy of the crosslinked complex.

Authors:  C J Strang; R C Siegel; M L Phillips; P H Poon; V N Schumaker
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

2.  Three step purification of C1q by DNA precipitation, ion exchange and lectin affinity chromatography.

Authors:  M Rhen; E Linder
Journal:  J Clin Pathol       Date:  1982-10       Impact factor: 3.411

3.  Antibody-independent and -dependent opsonization of group B Streptococcus requires the first component of complement C1.

Authors:  N J Levy; D L Kasper
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

4.  The role of C1, C1-inactivator and C4 in modulating immune precipitation.

Authors:  J A Schifferli; G Steiger; M Schapira
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

5.  Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.

Authors:  G Doekes; L A Vanes; M R Daha
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

6.  Activation of latent collagenase by serum proteinases that interact with immobilized immunoglobulin G.

Authors:  P C Armour; S Levi; E E Golds; A R Poole; J S Mort; P J Roughley
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

7.  Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway.

Authors:  S K Kochi; R C Johnson
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

8.  Antibody-independent activation of the complement system by mitochondria is mediated by cardiolipin.

Authors:  M C Peitsch; J Tschopp; A Kress; H Isliker
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

9.  The inhibition by lysine of the activation of the first component of complement, C1.

Authors:  A Takada; Y Takada
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

10.  A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.

Authors:  A de Agostini; P A Patston; V Marottoli; S Carrel; P C Harpel; M Schapira
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.